SMTL ID : 8v2o.1

Cryo-EM Structure of Wildtype Smooth Muscle Gamma Actin (ACTG2)

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

homo-pentamer

Ligands

5 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)

ADP.1: 17 residues within 4Å: Chain A: G.14, S.15, G.16, L.17, K.19, G.157, D.158, R.211, K.214, E.215, G.302, G.303, T.304, M.306, Y.307, K.337 Ligands: MG.2 15 PLIP interactions: 15 interactions with chain A Hydrogen bonds: A:G.14, A:S.15, A:G.16, A:L.17, A:D.158, A:D.158, A:D.158, A:K.214, A:E.215, A:G.303, A:K.337, A:K.337 Salt bridges: A:K.19, A:K.19 pi-Stacking: A:Y.307 ADP.3: 17 residues within 4Å: Chain B: G.14, S.15, G.16, L.17, K.19, G.157, D.158, R.211, K.214, E.215, G.302, G.303, T.304, M.306, Y.307, K.337 Ligands: MG.4 15 PLIP interactions: 15 interactions with chain B Hydrogen bonds: B:G.14, B:S.15, B:G.16, B:L.17, B:D.158, B:D.158, B:D.158, B:K.214, B:E.215, B:G.303, B:K.337, B:K.337 Salt bridges: B:K.19, B:K.19 pi-Stacking: B:Y.307 ADP.5: 17 residues within 4Å: Chain C: G.14, S.15, G.16, L.17, K.19, G.157, D.158, R.211, K.214, E.215, G.302, G.303, T.304, M.306, Y.307, K.337 Ligands: MG.6 15 PLIP interactions: 15 interactions with chain C Hydrogen bonds: C:G.14, C:S.15, C:G.16, C:L.17, C:D.158, C:D.158, C:D.158, C:K.214, C:E.215, C:G.303, C:K.337, C:K.337 Salt bridges: C:K.19, C:K.19 pi-Stacking: C:Y.307 ADP.7: 17 residues within 4Å: Chain D: G.14, S.15, G.16, L.17, K.19, G.157, D.158, R.211, K.214, E.215, G.302, G.303, T.304, M.306, Y.307, K.337 Ligands: MG.8 15 PLIP interactions: 15 interactions with chain D Hydrogen bonds: D:G.14, D:S.15, D:G.16, D:L.17, D:D.158, D:D.158, D:D.158, D:K.214, D:G.303, D:M.306, D:K.337, D:K.337 Salt bridges: D:K.19, D:K.19 pi-Stacking: D:Y.307 ADP.9: 17 residues within 4Å: Chain E: G.14, S.15, G.16, L.17, K.19, G.157, D.158, R.211, K.214, E.215, G.302, G.303, T.304, M.306, Y.307, K.337 Ligands: MG.10 15 PLIP interactions: 15 interactions with chain E Hydrogen bonds: E:G.14, E:S.15, E:G.16, E:L.17, E:D.158, E:D.158, E:D.158, E:K.214, E:E.215, E:G.303, E:K.337, E:K.337 Salt bridges: E:K.19, E:K.19 pi-Stacking: E:Y.307

5 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: D.12, Q.138 Ligands: ADP.1 No protein-ligand interaction detected (PLIP) MG.4: 3 residues within 4Å: Chain B: D.12, Q.138 Ligands: ADP.3 No protein-ligand interaction detected (PLIP) MG.6: 4 residues within 4Å: Chain C: D.12, Q.138, D.155 Ligands: ADP.5 No protein-ligand interaction detected (PLIP) MG.8: 4 residues within 4Å: Chain D: D.12, Q.138, D.155 Ligands: ADP.7 No protein-ligand interaction detected (PLIP) MG.10: 2 residues within 4Å: Chain E: Q.138 Ligands: ADP.9 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ceron, R.H. et al., Molecular Mechanisms of ACTG2 Mutations Linked to Visceral Myopathy. To Be Published

Release Date

2024-05-01

Peptides

Actin, gamma-enteric smooth muscle: ABCDE

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

E
E

Actin, gamma-enteric smooth muscle